Research Output per year
Fingerprint Dive into the research topics where Sanjay Goel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 18 Similar Profiles
Neoplasms
Medicine & Life Sciences
eribulin
Medicine & Life Sciences
irinotecan
Medicine & Life Sciences
Pharmacokinetics
Medicine & Life Sciences
Colorectal Neoplasms
Medicine & Life Sciences
oxaliplatin
Medicine & Life Sciences
Epidermal Growth Factor Receptor
Medicine & Life Sciences
docetaxel
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Publications 2002 2019
Anti-PD-1 monoclonal antibody MEDI0680 in a phase i study of patients with advanced solid malignancies
Naing, A., Infante, J., Goel, S., Burris, H., Black, C., Marshall, S., Achour, I., Barbee, S., May, R., Morehouse, C., Pollizzi, K., Song, X., Steele, K., Elgeioushi, N., Walcott, F., Karakunnel, J., Lorusso, P., Weise, A., Eder, J., Curti, B. & 1 others, , Aug 22 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 225.Research output: Contribution to journal › Article
Open Access
Kidney Neoplasms
Melanoma
Pharmacokinetics
Monoclonal Antibodies
T-Lymphocytes
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
Goel, S., Swami, U., Kumar, K., Dittrich, C., Reyderman, L., Jain, M., Aisner, J., Song, J. & Petrylak, D. P., Jan 1 2019, In : Cancer Chemotherapy and Pharmacology.Research output: Contribution to journal › Article
eribulin
Carboplatin
Non-Small Cell Lung Carcinoma
Labels
Tumors
A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction
Takebe, N., Beumer, J. H., Kummar, S., Kiesel, B. F., Dowlati, A., O'Sullivan Coyne, G., Piekarz, R., Rubinstein, L., Fogli, L. K., Vaishampayan, U., Goel, S., O'Bryant, C. L., El-Rayes, B. F., Chung, V., Lenz, H. J., Kim, R., Belani, C. P., Tuscano, J. M., Schelman, W., Moore, N. & 2 others, , Jan 1 2019, (Accepted/In press) In : British Journal of Clinical Pharmacology.Research output: Contribution to journal › Article
Open Access
Liver Diseases
Pharmacokinetics
Neoplasms
Maximum Tolerated Dose
Liver
Development and characterization of a genetic mouse model of KRAS mutated colorectal cancer
Maitra, R., Thavornwatanayong, T., Venkatesh, M. K., Chandy, C., Vachss, D., Augustine, T., Guzik, H., Koba, W., Liu, Q. & Goel, S., Nov 2 2019, In : International Journal of Molecular Sciences. 20, 22, 5677.Research output: Contribution to journal › Article
Open Access
Genetic Models
mice
Tumors
Colorectal Neoplasms
tumors
Differential efficacy of anti-vegf antibodies based on sex and race in a diverse cohort of advanced nonsquamous non-small cell lung cancer
Sukrithan, V., Barbaro, A., Chergui, A., Ko, B., Lin, J., Cheng, H. & Goel, S., Jan 1 2019, (Accepted/In press) In : American Journal of Clinical Oncology: Cancer Clinical Trials.Research output: Contribution to journal › Article
Non-Small Cell Lung Carcinoma
Vascular Endothelial Growth Factor A
Anti-Idiotypic Antibodies
Survival
Proportional Hazards Models